‘Smoker's paradox’ in young patients with acute myocardial infarction
- 3 May 2012
- journal article
- research article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 39 (7) , 630-635
Abstract
Summary: Of the patients suffering from acute myocardial infarction (AMI), smokers are younger than non‐smokers, which may be a major confounding factor causing ‘smoker's paradox’. Therefore, in the present study we evaluated the ‘smoker's paradox’ in young patients with AMI. In all, 1218 young AMI patients (≤ 45 years of age), comprising 990 smokers and 228 non‐smokers, were enrolled in the present study. In‐hospital and 8 months clinical outcomes were compared between the smokers and non‐smokers. Baseline clinical characteristics showed that smokers were more likely to be male (97.9% vs 72.4%; P < 0.001) and had a higher rate of ST‐segment elevation myocardial infarction (71.3% vs 59.5%; P = 0.001) than non‐smokers. Clinical outcomes showed that smokers had lower rates of in‐hospital cardiac death (0.8% vs 3.5%; P = 0.004), total death (0.8% vs 3.5%; P = 0.004) and 8 months cardiac death (1.1% vs 3.9%; P = 0.006) and total death (1.3% vs 4.4%; P = 0.005) than non‐smokers. Multivariable logistic analysis showed that current smoking was an independent protective predictor of 8 months cardiac death (odds ratio (OR) 0.25; 95% confidence interval (CI) 0.07–0.92; P = 0.037) and total death (OR 0.26; 95% CI 0.09–0.82; P = 0.021). Subgroup analysis in patients who underwent percutaneous coronary intervention after AMI showed that current smoking was an independent protective predictor of 8 months total major adverse cardiac events (OR 0.47; 95% CI 0.23–0.97; P = 0.041). Current smoking seems to be associated with better clinical outcomes in young patients with AMI, suggesting the existence of the ‘smoker's paradox’ in this particular subset of patients.Keywords
This publication has 25 references indexed in Scilit:
- Enhanced Clopidogrel Responsiveness in SmokersArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Clinical characteristics and mid‐term outcomes of acute myocardial infarction patients with prior cerebrovascular disease in an Asian population: Lessons from the Korea Acute Myocardial Infarction RegistryClinical and Experimental Pharmacology and Physiology, 2010
- Smoking, Clopidogrel, and Mortality in Patients With Established Cardiovascular DiseaseCirculation, 2009
- Interaction Between Cigarette Smoking and Clinical Benefit of ClopidogrelJACC, 2009
- Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction—The smoker's paradox revisitedAmerican Heart Journal, 2005
- Cigarette smoking and acute coronary syndromes: A multinational observational studyInternational Journal of Cardiology, 2005
- Influence of a history of smoking on short term (six month) clinical and angiographic outcome after successful coronary angioplastyHeart, 2000
- Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli thrombolytic national survey)JACC, 1996
- How do smokers differ from nonsmokers in their response to thrombolysis? (The TIMI-4 trial)The American Journal of Cardiology, 1995
- Increased frequency of restenosis in patients continuing to smoke cigarettes after percutaneous transluminal coronary angioplastyThe American Journal of Cardiology, 1988